Jubilant Pharmova Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Jubilant Pharmova has a total shareholder equity of ₹59.3B and total debt of ₹28.3B, which brings its debt-to-equity ratio to 47.7%. Its total assets and total liabilities are ₹119.2B and ₹60.0B respectively. Jubilant Pharmova's EBIT is ₹6.6B making its interest coverage ratio 2.8. It has cash and short-term investments of ₹10.8B.
Belangrijke informatie
47.7%
Verhouding schuld/eigen vermogen
₹28.25b
Schuld
| Rente dekkingsratio | 2.8x |
| Contant | ₹10.77b |
| Aandelen | ₹59.27b |
| Totaal verplichtingen | ₹59.97b |
| Totaal activa | ₹119.24b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 530019's short term assets (₹35.0B) exceed its short term liabilities (₹19.5B).
Langlopende schulden: 530019's short term assets (₹35.0B) do not cover its long term liabilities (₹40.5B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 530019's net debt to equity ratio (29.5%) is considered satisfactory.
Schuld verminderen: 530019's debt to equity ratio has reduced from 85.8% to 47.7% over the past 5 years.
Schuldendekking: 530019's debt is well covered by operating cash flow (27.2%).
Rentedekking: 530019's interest payments on its debt are not well covered by EBIT (2.8x coverage).